home / stock / cntg / cntg news

CNTG News and Press, Centogene N.V. From 12/28/21

Stock Information
Company Name: Centogene N.V.
Stock Symbol: CNTG
Market: NASDAQ
Website: centogene.com
Menu
CNTG CNTG Quote CNTG Short CNTG News CNTG Articles CNTG Message Board
Get CNTG Alerts

News, Short Squeeze, Breakout and More Instantly...
CNTG - ISIG, CPOP and BFRI among mid-day movers

Gainers: Insignia Systems (NASDAQ:ISIG) +83%.. Pop Culture (NASDAQ:CPOP) +24%. Regencell Bioscience RGC +20% BridgeBio Pharma BBIO +19%. Gamida Cell (NASDAQ:GMDA) +17%. ADDvantage Technologies (NASDAQ:AEY) +17%. Centogene (NASDAQ:CNTG) +14% Altamira Therapeu...
CNTG - CENTOGENE Wins Award in Digital Healthcare Innovation for Artificial Intelligence (AI) Platform Leading Biomarker Discovery

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it has been awarded the Health-i Aw...

CNTG - CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence - Biopharmaceutical Industry Veteran Kim Stratton Appointed as Interim CEO

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced today that its Chief Executive Officer, Andrin...

CNTG - Centogene N.V. (CNTG) Q3 2021 Earnings Call Transcript

Image source: The Motley Fool. Centogene N.V. (NASDAQ: CNTG) Q3 2021 Earnings Call Nov 24, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Centogene N.V. (CNTG) Q3 2021 Earnings Call Transcript

CNTG - Centogene N.V. (CNTG) CEO Andrin Oswald on Q3 2021 Results - Earnings Call Transcript

Centogene N.V. (CNTG) Q3 2021 Earnings Conference Call November 24, 2021, 8:30 AM ET Company Participants Lennart Streibel - Investor Relations Andrin Oswald - Chief Executive Officer Rene Just - Chief Financial Officer Conference Call Participants Puneet Souda - SVB Leerink Catherine Schulte...

CNTG - ESPR, LOV and BFRA among mid-day movers

Gainers: Biofrontera (NASDAQ:BFRI) +154%. Longeveron (NASDAQ:LGVN) +79%. Ocuphire Pharma (NASDAQ:OCUP) +36%. Society Pass (NASDAQ:SOPA) +24%. Biofrontera (NASDAQ:BFRA) +23%. Better Therapeutics (NASDAQ:BTTX) +20%. Applied UV (NASDAQ:AUVI) +19%. Standard Lithium (NYSE:SLI) +19%. Blue Star Food...

CNTG - Centogene N.V. 2021 Q3 - Results - Earnings Call Presentation

The following slide deck was published by Centogene N.V. in conjunction with their 2021 Q3 earnings call. For further details see: Centogene N.V. 2021 Q3 - Results - Earnings Call Presentation

CNTG - CENTOGENE to Announce Third Quarter 2021 Financial Results on November 24, 2021

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it will issue its financial result...

CNTG - CENTOGENE Expands Partnership With Agios to Generate Novel Insights Into Rare Blood Diseases

CAMBRIDGE, Mass., ROSTOCK, Germany and BERLIN, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, announced today that it has expanded its partnership with A...

CNTG - CENTOGENE Enrolls First Patient in Frontotemporal Dementia (FTD) Clinical Study

FTD is a rapidly progressing neurodegenerative disease; up to 30% of all cases worldwide caused by genetic mutations, including the progranulin gene mutation (FTD-GRN) Study will enroll and genetically test over 3,000 FTD patients at multiple sites in seven countries There are cur...
Previous 10 Next 10